Avoro Capital Advisors LLC Portfolio Holdings

Avoro Capital Advisors LLC

  • $6.86 Billion
  • Q4 2024

Avoro Capital Advisors LLC has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $6.86 Billion distributed in 39 stocks.

Among their holdings, we can observe that their the top five positions include companies like: United Therapeutics Corp with a value of $974M, Argenx Se with a value of $762M, Ascendis Pharma A/S with a value of $703M, Madrigal Pharmaceuticals, Inc. with a value of $626M, and Krystal Biotech, Inc. with a value of $412M.

Examining the 13F form we can see an increase of $217M in the current position value, from $6.65B to 6.86B.

Avoro Capital Advisors LLC is based out at New York, NY

Below you can find more details about Avoro Capital Advisors LLC portfolio as well as his latest detailed transactions.

Portfolio value $6.86 Billion
Healthcare: $6.86 Billion

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 39
  • Current Value $6.86 Billion
  • Prior Value $6.65 Billion
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 7 stocks
  • Additional Purchases 10 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 7 stocks
Track This Portfolio

Track Avoro Capital Advisors LLC Portfolio

Follow Avoro Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avoro Capital Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email